United States · 
Who invested in Cogent Biosciences?
Cogent Biosciences's investors include Wellington Management, Perceptive Advisors, Novo Holdings, TCG and RTW Investments LLC, and 2 more on record.
United States · Funded startup
Who invested in Cogent Biosciences
Funding summaryUpdated 26 Oct 2026
$200Mraised across 1 round since 2025, from 1 source
- Latest round
- Debt, $200MNov 2025
- Investors
- 7
The rounds
- Nov 2025
Founders and team
From Cogent Biosciences's own website: 8 on the team.
- Andrew RobbinsChief Executive Officer
- Courtney WatsonSenior Vice President, Head of Clinical Development Operations
- Brad BarnettChief Technology Officer
- Cole PinnowChief Commercial Officer
- Erin SchellhammerChief People Officer
- John GreenChief Financial Officer
- Arlene M. MorrisTeam
- Flatiron HealthTeam
Everyone who backed them
Adage Capital ManagementAsset manager1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Cogent Biosciences
How much has Cogent Biosciences raised?
Cogent Biosciences has raised $200M across 1 round since 2025.
When did Cogent Biosciences last raise?
Cogent Biosciences's most recent round was a Debt of $200M in Nov 2025.
What was Cogent Biosciences's biggest round?
Its most recent round, $200M in Nov 2025, is also its largest on record.
Who backed Cogent Biosciences first?
Cogent Biosciences's first round on record, in Nov 2025, was backed by Wellington Management, Perceptive Advisors and Novo Holdings and 4 others.
What stage is Cogent Biosciences at?
Cogent Biosciences's latest named round is a Debt, in Nov 2025.
Where is Cogent Biosciences based?
Cogent Biosciences is based in the United States.
Companies like Cogent Biosciences
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.